Tag: psychedelics stocks 2021
-
![How Cybin (CYBN.NE) is integrating new brain imaging technology with psychedelics]()
How Cybin (CYBN.NE) is integrating new brain imaging technology with psychedelics
Shamans among the machines In his 1999 lecture titled ‘Shamans Among the Machines’ Terence McKenna pointed out that “as far as people and machines are concerned, it was Ludwig von Bertalanffy who said in his book General Systems Theory: ‘people are not machines, but in every opportunity where they are allowed to behave like machines,…
-
![Revive Therapeutics (RVV.C) CEO Michael Frank likes the stock, buys the dip]()
Revive Therapeutics (RVV.C) CEO Michael Frank likes the stock, buys the dip
+135k shares in a downturn, my man The psychedelics sector is down bad this week. Just look at the psychedelics ETF PSYK.NE. It’s not an alarm or anything, things have been running pretty nicely the past couple of quarters and it was probably time for a correction. Any time a sector emerges this quickly there…
-
![How Field Trip (FTRP.CN) is scaling its ketamine therapy operations following a giant raise]()
How Field Trip (FTRP.CN) is scaling its ketamine therapy operations following a giant raise
Supersized bought deal Field Trip (FTRP.CN) announced on Friday that it raised a whopping $95.3M CAD through a bought deal. The deal was originally for proceeds of $50M CAD but was later upsized to $82.9M CAD. It was priced at $6.50 CAD per share, adding 12.8M shares to the pool, bringing the number of shares…
-
![Atai and Psybio: A closer look at two very different upcoming psychedelics IPO’s for 2021]()
Atai and Psybio: A closer look at two very different upcoming psychedelics IPO’s for 2021
IPO’s come in all shapes and sizes, some are giants with billionaire support, and others don’t have a pitch deck readily available. Investors get giddy with news of IPO’s as it signals a chance to get in early. It’s important to note that ‘getting in early’ isn’t a guarantee in an IPO, relatively speaking. Take…
-
![Compass Pathways (CMPS.Q) is rubbing investors the wrong way, again]()
Compass Pathways (CMPS.Q) is rubbing investors the wrong way, again
Cut the kumbaya shit Throwing the words profit and psychedelic drugs into a sentence would have lead to awkward and confused looks 5 years ago. But we have come a long way, and in that process, questions have arisen like: how do money and psychedelics mix? Psychedelic medicine advocates who have never been around the…
